Jul 23, 2021 | Webinar

Frequently asked questions in the management of urothelial cancer

Urinary biomarkers: Are we prepared to replace cystoscopies?

Watch the webinar presentations by Dr. Fernando Lozano and Dr. Alberto Breda

On June 7, 2021, HM Hospitales (Spain) organised the webinar “Frequently asked questions in the management of urothelial cancer”. This webinar included 2 presentations addressing the question “Urinary biomarkers: Are we prepared to replace cystoscopies?”:

Urinary biomarkers in bladder cancer, presented by Dr. Fernando Lozano (Vall d’Hebron Barcelona Hospital Campus)
Urinary biomarkers in upper urinary tract urothelial carcinoma (UTUC), presented Dr. Alberto Breda (Fundació Puigvert Barcelona)

Download the free slide resource and brochure

All updates

Other updates

Compare your opinion with peers and Prof. Joost Boormans

Feb 16, 2026 | Clinical case

Godelieve is a 77-year-old retired teacher. One year ago, she underwent TURBT of 1 small papillary tumour of 1 cm at the right bladder wall, which was detected during a cystoscopic examination for painless haematuria. The pathology report indicated pTa grade 2,...

Improving detection of high-grade recurrences missed by WLC using a urinary biomarker

Jan 16, 2026 | Publication

Improving detection of high-grade recurrences missed by WLC using a urinary biomarkerReviewed by Marek Babjuk Surveillance for non-muscle-invasive bladder cancer (NMIBC) relies on routine white-light cystoscopy (WLC) and urinary cytology as the diagnostic...

Compare your opinion with peers and Prof. Jørgen Bjerggaard Jensen

Sep 26, 2025 | Clinical case

Peter, a 72-year-old retired engineer, was diagnosed with T1 high-grade (HG) non-muscle-invasive bladder cancer (NMIBC) 18 months ago. Following a successful transurethral resection of the bladder tumour (TURBT) and re-TURBT without further pathology, he received a...

Privacy policy

Disclaimers

✉ info@bcamonitor.org